Markers of B-cell activation, including beta-2-microglobulin and B-cell activating factor of tumor necrosis factor family (BAFF), are significantly elevated in the serum of early RA patients compared to those with undifferentiated arthritis [10, 11]. The gene discussed is TNFSF13B; the disease is rheumatoid arthritis.